| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
37,845 |
18,857 |
$6.05M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
25,248 |
13,893 |
$1.10M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
927 |
745 |
$557K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
3,729 |
2,691 |
$433K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
6,475 |
5,606 |
$233K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
6,474 |
5,605 |
$222K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
6,757 |
5,686 |
$222K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
150 |
107 |
$211K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
243 |
181 |
$185K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
136 |
98 |
$166K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,869 |
1,959 |
$161K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
5,258 |
4,572 |
$126K |
| 87522 |
Neg quan hep c or qual rna |
2,759 |
2,407 |
$117K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,465 |
2,980 |
$84K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,899 |
4,395 |
$82K |
| 64483 |
|
160 |
112 |
$81K |
| 80053 |
Comprehensive metabolic panel |
7,827 |
6,285 |
$72K |
| 80074 |
|
1,371 |
1,276 |
$65K |
| 80367 |
|
2,072 |
1,428 |
$61K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
672 |
504 |
$56K |
| 86803 |
|
3,983 |
3,376 |
$55K |
| 64493 |
|
145 |
81 |
$54K |
| 87341 |
|
5,172 |
4,479 |
$52K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,717 |
5,928 |
$51K |
| 82607 |
|
3,192 |
2,787 |
$47K |
| 43235 |
|
100 |
84 |
$47K |
| 84481 |
|
2,952 |
2,556 |
$46K |
| 86705 |
|
3,911 |
3,286 |
$44K |
| 86709 |
|
3,650 |
3,070 |
$39K |
| 80368 |
|
5,773 |
2,292 |
$29K |
| 62323 |
|
94 |
72 |
$26K |
| 80333 |
|
1,206 |
818 |
$25K |
| 86704 |
|
1,659 |
1,550 |
$22K |
| 43450 |
|
181 |
145 |
$21K |
| 80364 |
|
785 |
602 |
$21K |
| 80363 |
|
5,217 |
1,912 |
$21K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
23 |
16 |
$20K |
| 86708 |
|
1,391 |
1,302 |
$19K |
| 83992 |
|
6,179 |
2,663 |
$18K |
| 84439 |
|
2,002 |
1,727 |
$18K |
| 84436 |
|
2,529 |
2,331 |
$18K |
| 84480 |
|
1,118 |
1,060 |
$17K |
| 80061 |
Lipid panel |
1,250 |
1,130 |
$14K |
| 80361 |
|
6,395 |
2,873 |
$13K |
| 80323 |
|
5,983 |
2,568 |
$12K |
| 86780 |
|
912 |
852 |
$12K |
| 36415 |
Collection of venous blood by venipuncture |
5,975 |
4,189 |
$12K |
| 80346 |
|
5,934 |
2,428 |
$10K |
| 82746 |
|
886 |
764 |
$10K |
| 80356 |
|
6,395 |
2,873 |
$10K |
| 80365 |
|
6,395 |
2,873 |
$10K |
| 80348 |
|
6,177 |
2,661 |
$9K |
| 80354 |
|
6,178 |
2,662 |
$9K |
| 20610 |
|
76 |
38 |
$9K |
| 64494 |
|
144 |
81 |
$9K |
| 80373 |
|
6,178 |
2,662 |
$9K |
| 80372 |
|
6,160 |
2,644 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,027 |
970 |
$9K |
| 80349 |
|
6,127 |
2,627 |
$9K |
| 81025 |
|
487 |
426 |
$8K |
| 80358 |
|
6,178 |
2,662 |
$8K |
| 80335 |
|
5,271 |
2,016 |
$8K |
| 80320 |
|
5,680 |
2,183 |
$7K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
46 |
41 |
$7K |
| 64484 |
|
41 |
27 |
$7K |
| 80360 |
|
3,065 |
1,696 |
$7K |
| 80353 |
|
6,196 |
2,680 |
$6K |
| 80359 |
|
6,178 |
2,662 |
$6K |
| 80369 |
|
5,300 |
1,934 |
$6K |
| 80366 |
|
1,626 |
1,087 |
$6K |
| 80355 |
|
1,626 |
1,087 |
$6K |
| 80345 |
|
5,711 |
2,239 |
$6K |
| 84403 |
|
345 |
332 |
$5K |
| 82533 |
|
252 |
247 |
$5K |
| 80370 |
|
436 |
333 |
$5K |
| 86593 |
|
902 |
851 |
$4K |
| 86592 |
|
902 |
851 |
$4K |
| 82670 |
|
282 |
275 |
$4K |
| 80325 |
|
1,393 |
1,070 |
$4K |
| 87340 |
|
296 |
277 |
$3K |
| 76000 |
|
26 |
24 |
$3K |
| 86376 |
|
272 |
263 |
$3K |
| 82248 |
|
655 |
537 |
$3K |
| 80324 |
|
4,742 |
1,572 |
$3K |
| 82627 |
|
236 |
230 |
$3K |
| 80371 |
|
873 |
687 |
$3K |
| 84146 |
|
236 |
230 |
$3K |
| 84153 |
|
201 |
165 |
$3K |
| 84270 |
|
259 |
253 |
$3K |
| 83001 |
|
175 |
171 |
$2K |
| 82962 |
|
642 |
278 |
$2K |
| 80332 |
|
4,221 |
1,255 |
$2K |
| 82150 |
|
189 |
187 |
$2K |
| 83735 |
|
234 |
228 |
$2K |
| 84154 |
|
118 |
116 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
19 |
16 |
$1K |
| 82728 |
|
226 |
223 |
$1K |
| J3490 |
Unclassified drugs |
328 |
213 |
$1K |
| 83540 |
|
240 |
237 |
$1K |
| 84466 |
|
220 |
219 |
$1K |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
18 |
13 |
$999.92 |
| 83690 |
|
187 |
186 |
$864.46 |
| 80336 |
|
114 |
85 |
$799.50 |
| 84144 |
|
115 |
115 |
$737.28 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
497 |
328 |
$645.03 |
| 84402 |
|
59 |
59 |
$598.82 |
| 84550 |
|
146 |
144 |
$561.79 |
| 83721 |
|
216 |
199 |
$521.90 |
| 84702 |
|
35 |
34 |
$515.95 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
1,639 |
1,080 |
$409.25 |
| 80374 |
|
356 |
220 |
$392.90 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
91 |
79 |
$380.90 |
| 82043 |
|
50 |
50 |
$324.43 |
| 81001 |
|
47 |
44 |
$155.72 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
207 |
145 |
$146.27 |
| 83002 |
|
13 |
13 |
$122.22 |
| 80362 |
|
58 |
55 |
$102.74 |
| 86431 |
|
13 |
12 |
$79.64 |
| 85045 |
|
15 |
13 |
$66.30 |
| 84100 |
|
13 |
13 |
$61.82 |
| 82950 |
|
30 |
29 |
$45.44 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
49 |
39 |
$32.16 |
| 85007 |
|
24 |
15 |
$26.59 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
645 |
438 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
204 |
126 |
$0.00 |
| L8699 |
Prosthetic implant, not otherwise specified |
85 |
58 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
174 |
130 |
$0.00 |
| 77002 |
|
94 |
50 |
$0.00 |